Literature DB >> 26787397

Prostate cancer: Co-targeting mTOR and AR-Vs is efficacious for CRPC.

Louise Stone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787397     DOI: 10.1038/nrurol.2016.12

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer.

Authors:  Minoru Kato; Carmen A Banuelos; Yusuke Imamura; Jacky K Leung; Daniel P Caley; Jun Wang; Nasrin R Mawji; Marianne D Sadar
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

  1 in total
  1 in total

1.  Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth.

Authors:  Jun Luo; Dan Wang; Xuechao Wan; Yangguang Xu; Yali Lu; Zhe Kong; Dujian Li; Wei Gu; Chenji Wang; Yao Li; Chaoneng Ji; Shaohua Gu; Yaoting Xu
Journal:  Onco Targets Ther       Date:  2020-09-18       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.